DaShenLin Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 8,054.554 million compared to CNY 6,940.333 million a year ago. Operating income was CNY 857.583 million compared to CNY 817.885 million a year ago. Net income was CNY 645.648 million compared to CNY 594.731 million a year ago. Basic earnings per share from continuing operations was CNY 0.82 compared to CNY 0.76 a year ago.